|
2024-10-16 |
2024-10-15 |
GV
Geplanter Verkauf
|
Chivukula Pad
Chief Scientific Officer & COO
Führungsperson
|
12.000
-2.7%
20,76
249.121 USD
|
12.000
-2.7%
|
20,76
|
249.121 USD
|
|
|
2024-06-14 |
2024-06-12 |
V
Verkauf
|
SASSINE ANDY
Chief Financial Officer
Geschäftsführender Verwaltungsratsmitglied
|
50.000
-18.5%
32,03
1.601.500 USD
|
50.000
-18.5%
|
32,03
|
1.601.500 USD
|
|
|
2024-06-07 |
2024-06-05 |
GV
Geplanter Verkauf
|
Chivukula Pad
Chief Scientific Officer & COO
Führungsperson
|
114
-0.0%
45,00
5.130 USD
|
114
-0.0%
|
45,00
|
5.130 USD
|
|
|
2024-06-04 |
2024-06-03 |
GV
Geplanter Verkauf
|
Chivukula Pad
Chief Scientific Officer & COO
Führungsperson
|
26.000
-5.5%
40,01
1.040.234 USD
|
26.000
-5.5%
|
40,01
|
1.040.234 USD
|
|
|
2024-03-27 |
2024-03-25 |
GV
Geplanter Verkauf
|
Chivukula Pad
Chief Scientific Officer & COO
Führungsperson
|
17.435
-3.6%
35,02
610.574 USD
|
17.435
-3.6%
|
35,02
|
610.574 USD
|
|
|
2024-03-21 |
2024-03-19 |
GV
Geplanter Verkauf
|
Chivukula Pad
Chief Scientific Officer & COO
Führungsperson
|
8.565
-1.7%
35,01
299.839 USD
|
8.565
-1.7%
|
35,01
|
299.839 USD
|
|
|
2023-11-03 |
2023-11-01 |
GV
Geplanter Verkauf
|
Chivukula Pad
Chief Scientific Officer & COO
Führungsperson
|
5.000
-1.0%
18,72
93.602 USD
|
5.000
-1.0%
|
18,72
|
93.602 USD
|
|
|
2023-10-04 |
2023-10-02 |
GV
Geplanter Verkauf
|
Chivukula Pad
Chief Scientific Officer & COO
Führungsperson
|
5.000
-1.0%
25,61
128.062 USD
|
5.000
-1.0%
|
25,61
|
128.062 USD
|
|
|
2023-09-05 |
2023-09-01 |
GV
Geplanter Verkauf
|
Chivukula Pad
Chief Scientific Officer & COO
Führungsperson
|
5.000
-1.0%
31,45
157.264 USD
|
5.000
-1.0%
|
31,45
|
157.264 USD
|
|
|
2023-08-03 |
2023-08-01 |
GV
Geplanter Verkauf
|
Chivukula Pad
Chief Scientific Officer & COO
Führungsperson
|
5.000
-1.0%
34,91
174.550 USD
|
5.000
-1.0%
|
34,91
|
174.550 USD
|
|
|
2023-07-18 |
2023-07-14 |
GV
Geplanter Verkauf
|
Kummerfeld Keith C
See Remarks
Führungsperson
|
6.968
-88.0%
35,00
243.880 USD
|
6.968
-88.0%
|
35,00
|
243.880 USD
|
|
|
2023-07-18 |
2023-07-14 |
GV
Geplanter Verkauf
|
Chivukula Pad
Chief Scientific Officer & COO
Führungsperson
|
25.000
-4.6%
35,01
875.250 USD
|
25.000
-4.6%
|
35,01
|
875.250 USD
|
|
|
2023-07-07 |
2023-07-03 |
GV
Geplanter Verkauf
|
Chivukula Pad
Chief Scientific Officer & COO
Führungsperson
|
5.000
-0.9%
28,75
143.750 USD
|
5.000
-0.9%
|
28,75
|
143.750 USD
|
|
|
2023-06-05 |
2023-06-01 |
GV
Geplanter Verkauf
|
Chivukula Pad
Chief Scientific Officer & COO
Führungsperson
|
5.000
-0.9%
27,16
135.800 USD
|
5.000
-0.9%
|
27,16
|
135.800 USD
|
|
|
2023-05-12 |
2023-05-11 |
GV
Geplanter Verkauf
|
Chivukula Pad
Chief Scientific Officer & COO
Führungsperson
|
7.925
-1.4%
30,24
239.652 USD
|
7.925
-1.4%
|
30,24
|
239.652 USD
|
|
|
2023-05-12 |
2023-05-10 |
GV
Geplanter Verkauf
|
Chivukula Pad
Chief Scientific Officer & COO
Führungsperson
|
17.075
-2.9%
30,00
512.250 USD
|
17.075
-2.9%
|
30,00
|
512.250 USD
|
|
|
2023-05-03 |
2023-05-01 |
GV
Geplanter Verkauf
|
Chivukula Pad
Chief Scientific Officer & COO
Führungsperson
|
5.000
-0.9%
25,93
129.650 USD
|
5.000
-0.9%
|
25,93
|
129.650 USD
|
|
|
2023-04-19 |
2023-04-18 |
GV
Geplanter Verkauf
|
Kummerfeld Keith C
See Remarks
Führungsperson
|
6.968
-88.0%
28,18
196.358 USD
|
6.968
-88.0%
|
28,18
|
196.358 USD
|
|
|
2023-04-05 |
2023-04-03 |
GV
Geplanter Verkauf
|
Chivukula Pad
Chief Scientific Officer & COO
Führungsperson
|
5.000
-0.8%
25,38
126.900 USD
|
5.000
-0.8%
|
25,38
|
126.900 USD
|
|
|
2023-03-08 |
2023-03-06 |
GV
Geplanter Verkauf
|
Chivukula Pad
Chief Scientific Officer & COO
Führungsperson
|
5.000
-0.8%
16,07
80.350 USD
|
5.000
-0.8%
|
16,07
|
80.350 USD
|
|
